70 related articles for article (PubMed ID: 2881897)
1. Evaluation of a new bronchodilating compound (broxaterol) administered as a pressurized aerosol.
Robuschi M; Simone P; Vaghi A; Ventresca GP; Bianco S
Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):101-4. PubMed ID: 2881897
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the bronchodilating activity and the tolerability of broxaterol administered as a solution by inhalation.
Ferrari M; Olivieri M; Biasin C; Pisati R; Lodola E; Lo Cascio V
Arzneimittelforschung; 1993 May; 43(5):553-8. PubMed ID: 8101082
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the bronchodilator effects of broxaterol and salbutamol.
Casali L; Rossi A; Manazza P; Colombo ML; Zoia MC
Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):93-7. PubMed ID: 2900816
[TBL] [Abstract][Full Text] [Related]
4. Bronchodilation and beta 2-selectivity of broxaterol in asthmatics: a crossover, single-blind, terbutaline- and placebo-controlled study.
Petraglia A; Gurrieri G; Scarpitta M; Pisati R; Ansalone D
Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):365-70. PubMed ID: 1359998
[TBL] [Abstract][Full Text] [Related]
5. Early bronchodilating effect of a new oral beta-2-receptor agonist (broxaterol) in bronchial asthma.
Chetta A; Garavaldi G; Cuomo A; Gurrieri G; Olivieri D
Respiration; 1988; 53(4):220-4. PubMed ID: 2902671
[TBL] [Abstract][Full Text] [Related]
6. Dose-response comparison of broxaterol and salbutamol pressurized aerosols.
Simone P; Borgia M; Torre L; Ventresca GP
Eur J Clin Pharmacol; 1990; 39(6):565-8. PubMed ID: 1982761
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of a new beta 2-agonist (broxaterol) on bronchospasm induced by methacholine (blind study versus salbutamol)].
Corrias A; Corona GB; Pelosi U; Corda R
Pediatr Med Chir; 1989; 11(1):61-3. PubMed ID: 2566160
[TBL] [Abstract][Full Text] [Related]
8. Bronchodilating activity of broxaterol transdermal patch and its protective effect on bronchial constriction induced by inhaled distilled water mist.
Robuschi M; Gambaro G; Spagnotto S; Scuri M; Fai V; Lodola E; Pisati R; Bianco S
Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):407-11. PubMed ID: 1684178
[TBL] [Abstract][Full Text] [Related]
9. Broxaterol (Z.1170), a new oral beta 2-agonist compared with salbutamol.
Perruchoud AP; Bründler H; Godly R; Imhof E; Herzog H
Respiration; 1987; 51(2):113-8. PubMed ID: 2884706
[TBL] [Abstract][Full Text] [Related]
10. Acute ventilatory and gas-exchange effects of a new beta-2 agonist, broxaterol, in asthmatics.
Tantucci C; Burni B; Dottorini ML; Malerba M; Peccini F; Gurrieri G; Sorbini CA; Grassi V
Int J Clin Pharmacol Res; 1990; 10(3):183-9. PubMed ID: 1977709
[TBL] [Abstract][Full Text] [Related]
11. Broxaterol, a new beta 2-adrenoceptor agonist compared to salbutamol in asthmatics, oral and inhalation treatment.
Löfdahl CG; Sigvaldasson A; Skoogh BE; Svedmyr N
Respiration; 1989; 55 Suppl 2():15-9. PubMed ID: 2572036
[TBL] [Abstract][Full Text] [Related]
12. Broxaterol: a double-blind clinical trial comparing broxaterol and salbutamol.
Rampulla C; Corsico R; Majani U; Lodola E
Respiration; 1985; 47(4):299-302. PubMed ID: 2861630
[TBL] [Abstract][Full Text] [Related]
13. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
[TBL] [Abstract][Full Text] [Related]
14. Negligible metabolic effects of long-term oral treatment with a new beta 2-agonist: broxaterol.
Petraglia A; Scarpitta M; Ansalone D; Gurrieri G; Galzerano V; Calvanese RC; Federico S; Zinno A
Int J Clin Pharmacol Res; 1990; 10(5):299-304. PubMed ID: 1981879
[TBL] [Abstract][Full Text] [Related]
15. Role of broxaterol in bronchial hyperresponsiveness.
Bianco S
Respiration; 1989; 55 Suppl 2():20-7. PubMed ID: 2572037
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of the effect of a single oral dose of theophylline and etamiphyllin in children with asthma].
Vázquez C; Labayru MT
An Esp Pediatr; 1984 Nov; 21(8):739-46. PubMed ID: 6529027
[TBL] [Abstract][Full Text] [Related]
17. [Protective action of broxaterol in bronchial spasm induced by ultrasonic mist].
Aversa C; Scorrano F; Scoditti S; Pancosta G; Stomeo S
Arch Monaldi Mal Torace; 1988; 43(3):243-8. PubMed ID: 2908378
[No Abstract] [Full Text] [Related]
18. [Efficacy of broxaterol (vs salbutamol) in asthma induced by physical exercise in children].
Corrias A; Pelosi U; Corona GB; Minelli R; Peri M; Corda R
Pediatr Med Chir; 1989; 11(2):161-3. PubMed ID: 2569730
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
Cass LM; Gunawardena KA; Macmahon MM; Bye A
Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
[TBL] [Abstract][Full Text] [Related]
20. Preliminary study on the effect of broxaterol on bronchial hyperresponsiveness in asthmatic children: influence of allergen exposure.
Benedetti M; Spezia E; Comis A; Marcer G; Boner AL
Respiration; 1993; 60(6):319-24. PubMed ID: 7904767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]